NW PharmaTech is a clinical-stage biopharmaceutical company with a ‘Nature to Medicine’ strategy and a focus on mental health. We are utilising the latest technological developments in clinical research and drug design to bring to market a new generation of medicines based on natural compounds with unique and promising therapeutic properties (starting with cannabidiol). These molecules can help patients with mental health conditions, return towards a state of homeostasis, allowing them to live longer and happier lives. We plan to achieve this through a strategy rooted in rigorous science and a best-in-class team with long standing expertise in the pharmaceutical, life sciences and cannabinoid sectors. Our patented drug delivery technology allows us to harness the benefits of natural compounds, whilst providing a route to defensible commercialisation. Our initial target indications in clinical development are within the mental health complex and are using our CBD micelle formulation. Our integrated supply chain ensures consistent therapeutic product with reproducible results, with our CBD API having a purity of 99.8-99.95%.